BCL6 degradation agent for cyanopyridine and cyanopyrimidine
Compounds, compositions, and methods for treating diseases or conditions characterized by aberrant B cell lymphoma 6 (BCL6) activity are described. 描述了治疗以异常B细胞淋巴瘤6(BCL6)活性为特征的疾病或病症的化合物、组合物和方法。
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Compounds, compositions, and methods for treating diseases or conditions characterized by aberrant B cell lymphoma 6 (BCL6) activity are described.
描述了治疗以异常B细胞淋巴瘤6(BCL6)活性为特征的疾病或病症的化合物、组合物和方法。 |
---|